×
IPSEN Total Assets 2016-2024 | IPSEY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
IPSEN total assets for the quarter ending December 31, 2024 were
$6.968B
, a
18.89% increase
year-over-year.
IPSEN total assets for 2024 were
$6.968B
, a
1.82% increase
from 2023.
IPSEN total assets for 2023 were
$6.843B
, a
15.82% increase
from 2022.
IPSEN total assets for 2022 were
$5.908B
, a
0.25% decline
from 2021.
View More
IPSEN Total Assets 2016-2024 | IPSEY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
IPSEN total assets for 2024 were
$6.968B
, a
1.82% increase
from 2023.
IPSEN total assets for 2023 were
$6.843B
, a
15.82% increase
from 2022.
IPSEN total assets for 2022 were
$5.908B
, a
0.25% decline
from 2021.
Related Stocks
Company Name
Market
Cap
Chugai Pharmaceutical (CHGCY)
$81.3B
Zoetis (ZTS)
$67.2B
Daiichi Sankyo, - (DSNKY)
$46.3B
Takeda Pharmaceutical (TAK)
$45.6B
BeOne Medicines - (ONC)
$33.5B
Sandoz Group AG (SDZNY)
$26B
Summit Therapeutics (SMMT)
$19.9B
Merck (MKKGY)
$16.9B
Shionogi (SGIOY)
$14.3B
United Therapeutics (UTHR)
$13.4B
Neurocrine Biosciences (NBIX)
$13.3B
Orion OYJ (ORINY)
$11.4B
Stevanato Group S.p.A (STVN)
$7.7B
Corcept Therapeutics (CORT)
$7.2B
Grifols, S.A (GRFS)
$7.2B
Ionis Pharmaceuticals (IONS)
$6.6B
Madrigal Pharmaceuticals (MDGL)
$6.5B
Hikma Pharmaceuticals Plc (HKMPF)
$6.2B
Ono Pharmaceutical (OPHLF)
$5.2B
Soleno Therapeutics (SLNO)
$4.2B
Hypermarcas (HYPMY)
$3B
Crinetics Pharmaceuticals (CRNX)
$2.7B
Catalyst Pharmaceuticals (CPRX)
$2.6B
NewAmsterdam Pharma (NAMS)
$2.6B
AMNEAL PHARMACEUTICALS, INC (AMRX)
$2.5B
Centessa Pharmaceuticals (CNTA)
$2B
Ocular Therapeutix (OCUL)
$1.9B
Endo (NDOI)
$1.8B
ARS Pharmaceuticals (SPRY)
$1.7B
BioCryst Pharmaceuticals (BCRX)
$1.7B